Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018;20(1):31-37.
doi: 10.3909/riu02001BCA.

Bladder Cancer Academy 2018 Selected Summaries

Nermarie Velázquez  1
Affiliations

Bladder Cancer Academy 2018 Selected Summaries

Nermarie Velázquez. Rev Urol. 2018.
No abstract available

Keywords: Immunotherapy; Intravesical chemotherapy; Renal masses; Transurethral resection of a bladder tumor (TURBT); Trimodal therapy (TMT); Urinary biomarkers.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Urine tumor markers in bladder cancer diagnosis: overview of urine tumor markers, genetic aberrations in bladder cancer, fluorescence in situ hybridization. Medscape website. https://emedicine.medscape.com/article/1953022-overview. Accessed March 18, 2018.
    1. Shariat SF, Karam JA, Lotan Y. Critical evaluation of urinary markers for bladder cancer detection and monitoring. Rev Urol. 2008;10:120–135. - PMC - PubMed
    1. Villicana P, Whiting B, Goodison S. Urine-based assays for the detection of bladder cancer. Biomark Med. 2009;3:265–274. - PMC - PubMed
    1. Fradet Y, Lockhard C. Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt™. Can J Urol. 1997;4:400–405. - PubMed
    1. Gayed BA, Seideman C, Lotan Y. Cost-effectiveness of fluorescence in situ hybridization in patients with atypical cytology for the detection of urothelial carcinoma. J Urol. 2013;190:1181–1186. - PubMed

LinkOut - more resources